ChemicalBook--->CAS DataBase List--->2395009-34-2

2395009-34-2

2395009-34-2 Structure

2395009-34-2 Structure
IdentificationBack Directory
[Name]

Methanone, [1,4-bis(4-aminophenyl)-1H-pyrrol-3-yl](3,4,5-trimethoxyphenyl)-
[CAS]

2395009-34-2
[Synonyms]

Anticancer agent 49
Methanone, [1,4-bis(4-aminophenyl)-1H-pyrrol-3-yl](3,4,5-trimethoxyphenyl)-
[Molecular Formula]

C26H25N3O4
[MOL File]

2395009-34-2.mol
[Molecular Weight]

443.49
Chemical PropertiesBack Directory
[Boiling point ]

708.8±60.0 °C(Predicted)
[density ]

1.24±0.1 g/cm3(Predicted)
[pka]

4.01±0.10(Predicted)
Hazard InformationBack Directory
[Uses]

Anticancer agent 49 (compound 69) is a broad spectrum anticancer agent. Anticancer agent 49 inhibits tubulin polymerization. Anticancer agent 49 shows antiproliferative activity. Anticancer agent 49 has the potential for the research of solid and hematological tumors[1].
[References]

[1] Puxeddu M, et al. Structure-activity relationship studies and in vitro and in vivo anticancer activity of novel 3-aroyl-1,4-diarylpyrroles against solid tumors and hematological malignancies. Eur J Med Chem. 2020 Jan 1;185:111828. DOI:10.1016/j.ejmech.2019.111828
2395009-34-2 suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +17819995354 , +17819995354
Website:
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Website: https://www.targetmol.cn/
Tags:2395009-34-2 Related Product Information

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.